De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock

Author:

Routsi Christina12,Gkoufa Aikaterini2,Arvaniti Kostoula3,Kokkoris Stelios1,Tourtoglou Alexandros4,Theodorou Vassiliki5,Vemvetsou Anna3,Kassianidis Georgios6,Amerikanou Athena6,Paramythiotou Elisabeth7,Potamianou Efstathia8,Ntorlis Kyriakos9,Kanavou Angeliki10,Nakos Georgios11,Hassou Eleftheria12,Antoniadou Helen12,Karaiskos Ilias213ORCID,Prekates Athanasios4,Armaganidis Apostolos7,Pnevmatikos Ioannis5,Kyprianou Miltiades14,Zakynthinos Spyros1,Poulakou Garyfallia215,Giamarellou Helen213

Affiliation:

1. 1st Department of Intensive Care, School of Medicine, National and Kapodistrian University of Athens, ‘Evangelismos’ Hospital, Athens, Greece

2. Hellenic Society of Antimicrobial Chemotherapy, Greece

3. Department of Intensive Care, ‘Papageorgiou’ Hospital, Thessaloniki, Greece

4. Department of Intensive Care, ‘Tzaneio’ Hospital, Piraeus, Greece

5. Department of Intensive Care, Democritus University of Thrace, Alexandroupolis University Hospital, Alexandroupolis, Greece

6. Department of Intensive Care, ‘Red Cross’ Hospital, Athens, Greece

7. 2nd Department of Intensive Care, School of Medicine, National and Kapodistrian University of Athens, ‘Attikon’ Hospital, Athens, Greece

8. 1st Department of Respiratory Medicine, Intensive Care Unit, School of Medicine, National and Kapodistrian University of Athens, ‘Sotiria’ Hospital, Athens, Greece

9. Department of Intensive Care, ‘Konstantopouleio’ Hospital, Athens, Greece

10. Department of Intensive Care, ‘Thriassio’ Hospital, Elefsina, Greece

11. Department of Intensive Care, ‘Henry Dunant’ Hospital Center, Athens, Greece

12. Department of Intensive Care, ‘Gennimatas’ Hospital, Thessaloniki, Greece

13. Hygeia General Hospital, Athens, Greece

14. Hellenic Institute for the Study of Sepsis, Greece

15. School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Abstract

Abstract Background De-escalation of empirical antimicrobial therapy, a key component of antibiotic stewardship, is considered difficult in ICUs with high rates of antimicrobial resistance. Objectives To assess the feasibility and the impact of antimicrobial de-escalation in ICUs with high rates of antimicrobial resistance. Methods Multicentre, prospective, observational study in septic patients with documented infections. Patients in whom de-escalation was applied were compared with patients without de-escalation by the use of a propensity score matching by SOFA score on the day of de-escalation initiation. Results A total of 262 patients (mean age 62.2 ± 15.1 years) were included. Antibiotic-resistant pathogens comprised 62.9%, classified as MDR (12.5%), extensively drug-resistant (49%) and pandrug-resistant (1.2%). In 97 (37%) patients de-escalation was judged not feasible in view of the antibiotic susceptibility results. Of the remaining 165 patients, judged as patients with de-escalation possibility, de-escalation was applied in 60 (22.9%). These were matched to an equal number of patients without de-escalation. In this subset of 120 patients, de-escalation compared with no de-escalation was associated with lower all-cause 28 day mortality (13.3% versus 36.7%, OR 0.27, 95% CI 0.11–0.66, P = 0.006); ICU and hospital mortality were also lower. De-escalation was associated with a subsequent collateral decrease in the SOFA score. Cox multivariate regression analysis revealed de-escalation as a significant factor for 28 day survival (HR 0.31, 95% CI 0.14–0.70, P = 0.005). Conclusions In ICUs with high levels of antimicrobial resistance, feasibility of antimicrobial de-escalation was limited because of the multi-resistant pathogens isolated. However, when de-escalation was feasible and applied, it was associated with lower mortality.

Funder

Hellenic Institute for the Study of Sepsis

Hellenic Society of Antimicrobial Chemotherapy

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3